Title

Bupivacaine Liposomal versus Bupivacaine: Comparative Review

Document Type

Article

Publication Date

6-1-2014

Abstract

Bupivacaine liposomal injection was recently approved by the US Food and Drug Administration (FDA) as a local anesthetic for use in management of postsurgical pain in adults. When compared to placebo, bupivacaine liposomal decreases postoperative pain and opioid use. This review examines the efficacy of bupivacaine liposomal when compared to conventional bupivacaine ± epinephrine using published and unpublished data provided to the FDA by the manufacturer.

DOI

https://doi.org/10.1310%2Fhpj4906-539

Additional Files

Share

COinS